This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Безопасность и риск фармакотерапии (Jun 2022)
Affiliations
Read online
The article presents the results of pharmacoeconomic studies ofadverse reactions of developed drugs in Russian Federation